The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.

Background: Whether the underlying disease affects the outcomes in pyoderma gangrenosum (PG) is unclear.Objectives: To determine the impact of comorbid disease associations and concomitant procedural treatments on patient outcomes in hospitalizations of patients with PG.Methods: A cross-sectional an...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of the American Academy of Dermatology Vol. 79; no. 4; pp. 659 - 660
Autores principales: Kaffenberger, Benjamin H., Hinton, Alice, Krishna, Somashekar G.
Formato: research tables/charts Journal Article
Publicado: Elsevier B.V. Oct2018
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=131816138&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 131816138
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01909622
        1ZF
      jtl: Journal of the American Academy of Dermatology
      issn: 01909622
      maglogo: N
    pubinfo:
      dt: Oct2018
      vid: 79
      iid: 4
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        131816138
        131816138
        NLM29438762
        131816138
        10.1016/j.jaad.2018.02.007
        NLM29438762
        131816138
      ppf: 659
      ppct: 1
      formats:
      tig:
        atl: The impact of underlying disease state on outcomes in patients with pyoderma gangrenosum: A national survey.
      aug:
        au:
          Kaffenberger, Benjamin H.
          Hinton, Alice
          Krishna, Somashekar G.
        affil: Department of Internal Medicine, Division of Dermatology, The Ohio State University Wexner Medical Center, Columbus, Ohio
      sug:
        subj:
          Inflammatory Bowel Diseases Epidemiology
          Vasculitis Epidemiology
          Pyoderma Gangrenosum Epidemiology
          Cause of Death
          Hospital Mortality
          Arthritis, Rheumatoid Diagnosis
          Pyoderma Gangrenosum Therapy
          Arthritis, Rheumatoid Epidemiology
          Survival Analysis
          Female
          Cross Sectional Studies
          Hematologic Neoplasms Diagnosis
          Ohio
          Pyoderma Gangrenosum Diagnosis
          Resource Databases
          Risk Assessment
          Logistic Regression
          Severity of Illness Indices
          Retrospective Design
          Hospitalization Statistics and Numerical Data
          Inflammatory Bowel Diseases Diagnosis
          Prognosis
          Vasculitis Diagnosis
          Linear Regression
          Multivariate Analysis
          Hematologic Neoplasms Epidemiology
          Comorbidity
          Treatment Outcomes
          Male
          Funding Source
          Female
          Male
      ab: Background: Whether the underlying disease affects the outcomes in pyoderma gangrenosum (PG) is unclear.Objectives: To determine the impact of comorbid disease associations and concomitant procedural treatments on patient outcomes in hospitalizations of patients with PG.Methods: A cross-sectional analysis of the National Inpatient Sample for hospitalizations of patients with PG from the years 2002 to 2011, analyzing in-hospital mortality rate and health care resource utilization.Results: Inflammatory bowel disease was the most frequent comorbid association, followed by inflammatory arthritis, hematologic malignancies/dyscrasia, and vasculitis. Multivariable modeling showed that vasculitis and hematologic malignancy/dyscrasia, when compared with inflammatory bowel disease, were associated with a 4-fold to 6-fold increased risk of in-hospital mortality and increasing health care resource utilization. Inpatient procedural interventions, including skin grafts, biopsies, and debridement, did not affect mortality and were associated with an increased length of stay.Limitations: The database does not account for outpatient follow-up; additionally, there was a low rate of coded comorbid conditions.Conclusions: Comprehensive evaluation to determine the underlying comorbidity for patients with PG is important for patient risk stratification.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N